Large-scale testing (Phase 3)Study completedNCT00538850What this trial is testingFentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainWho this might be right forCancer INSYS Therapeutics Inc 130
Early research (Phase 1)Study completedNCT00005842What this trial is testingTrastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic CancerWho this might be right forCancer National Cancer Institute (NCI) 24
Early research (Phase 1)Study completedNCT01900158What this trial is testingA Phase I/II Safety and Efficacy Study of PCI of Gemcitabine and Chemotherapy in Patients With CholangiocarcinomasWho this might be right forCholangiocarcinoma PCI Biotech AS 24
Testing effectiveness (Phase 2)Study completedNCT00021047What this trial is testingEpirubicin, Carboplatin, and Capecitabine in Treating Patients With Unresectable Locally Advanced, Metastatic, or Recurrent Solid TumorWho this might be right forEsophageal CancerExtrahepatic Bile Duct CancerGastric Cancer+3 more National Institutes of Health Clinical Center (CC)
Early research (Phase 1)WithdrawnNCT03117855What this trial is testingCapecitabine and Y-90 Radioembolization in Treating Patients With Advanced Bile Duct Cancer in the Liver That Cannot Be Removed by SurgeryWho this might be right forBile Duct AdenocarcinomaStage III Intrahepatic CholangiocarcinomaStage IVA Intrahepatic Cholangiocarcinoma+1 more City of Hope Medical Center
Testing effectiveness (Phase 2)Study completedNCT02128282What this trial is testingStudy of CX-4945 in Combination With Gemcitabine and Cisplatin for Frontline Treatment of CholangiocarcinomaWho this might be right forCholangiocarcinoma Senhwa Biosciences, Inc. 127
Early research (Phase 1)Study completedNCT00003548What this trial is testingAminocamptothecin in Treating Patients With Advanced Cancer of the Peritoneal CavityWho this might be right forCancer NYU Langone Health 20
Testing effectiveness (Phase 2)Study completedNCT03579771What this trial is testingGemcitabine, Cisplatin, and Nab-Paclitaxel Before Surgery in Patients With High-Risk Liver Bile Duct CancerWho this might be right forResectable CholangiocarcinomaStage IB Intrahepatic Cholangiocarcinoma AJCC v8Stage II Intrahepatic Cholangiocarcinoma AJCC v8+3 more Emory University 30
Testing effectiveness (Phase 2)Study completedNCT00004895What this trial is testingOctreotide as Palliative Therapy for Cancer-Related Bowel Obstruction That Cannot Be Removed by SurgeryWho this might be right forColorectal CancerConstipation, Impaction, and Bowel ObstructionExtrahepatic Bile Duct Cancer+7 more Northwestern University
Early research (Phase 1)Study completedNCT00654160What this trial is testingIrinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal CancerWho this might be right forAnal CancerCarcinoma of the AppendixColorectal Cancer+9 more Mayo Clinic 7
Testing effectiveness (Phase 2)Active Not RecruitingNCT03368963What this trial is testingTAS102 in Combination With NAL-IRI in Advanced GI CancersWho this might be right forColorectal AdenocarcinomaGastric AdenocarcinomaMetastatic Pancreatic Adenocarcinoma+11 more Emory University 64
Early research (Phase 1)Study completedNCT00101972What this trial is testingRAV12 in Treating Patients With Metastatic or Recurrent AdenocarcinomaWho this might be right forCancer MacroGenics 53
Early research (Phase 1)Study completedNCT00003439What this trial is testingInterleukin-12 in Treating Patients With Refractory Advanced-Stage Ovarian Cancer or Abdominal CancerWho this might be right forCancer National Cancer Institute (NCI) 36
Early research (Phase 1)Study completedNCT00003867What this trial is testingIrinotecan and Capecitabine in Treating Patients With Solid TumorsWho this might be right forCancer Montefiore Medical Center 30
Early research (Phase 1)Study completedNCT00003427What this trial is testingOxaliplatin Plus Irinotecan in Treating Patients With Metastatic Gastrointestinal CancerWho this might be right forAnal CancerColorectal CancerEsophageal Cancer+7 more Memorial Sloan Kettering Cancer Center 36
Testing effectiveness (Phase 2)Active Not RecruitingNCT04068194What this trial is testingTesting the Combination of New Anti-cancer Drug Peposertib With Avelumab and Radiation Therapy for Advanced/Metastatic Solid Tumors and Hepatobiliary MalignanciesWho this might be right forLocally Advanced Malignant Solid NeoplasmLocally Advanced Unresectable CholangiocarcinomaLocally Advanced Unresectable Gallbladder Carcinoma+7 more National Cancer Institute (NCI) 103
Early research (Phase 1)Study completedNCT00486356What this trial is testingCapecitabine, Epirubicin, and Carboplatin in Treating Patients With Progressive, Unresectable, or Metastatic CancerWho this might be right forExtrahepatic Bile Duct CancerGallbladder CancerGastric Cancer+2 more University of Nebraska 46
Large-scale testing (Phase 3)Study completedNCT00016380What this trial is testingOndansetron With/Out Dexamethasone to Prevent Vomiting in Patients Receiving Radiation to the Upper AbdomenWho this might be right forCancer NCIC Clinical Trials Group 211
Not applicableWithdrawnNCT04404647What this trial is testingIrreversible Electroporation of Unresectable Liver TumorsWho this might be right forLiver MetastasesHepatocellular CarcinomaBile Duct Cancer Ole Thorlacius-Ussing, MD, DMSc, Professor of Surgery
Early research (Phase 1)Ended earlyNCT05346484What this trial is testingCF33-hNIS (VAXINIA), an Oncolytic Virus, as Monotherapy or in Combination With Pembrolizumab in Adults With Metastatic or Advanced Solid TumorsWho this might be right forSolid TumorSolid CarcinomaSolid Tumor, Adult+4 more Imugene Limited 66